Cephalalgia

Cephalalgia is the official journal of the International Headache Society, published monthly by SAGE since 1981, and covers research on all forms of headache, with a 2025 Journal Impact Factor of 5.8.《头痛》（Cephalalgia）是国际头痛学会的官方期刊，1981 年创刊，现由（SAGE）按月出版，覆盖各类头痛的研究，2025 年期刊影响因子为 5.8。

Scope

• The journal publishes original peer reviewed papers on all aspects of headache, from pathophysiology and genetics to clinical management.本刊发表关于头痛各个方面的原创同行评审论文，从病理生理与遗传学到临床处置。
• Primary headache disorders, particularly migraine, tension-type headache and the trigeminovascular system, dominate the basic science content.原发性头痛，尤其是偏头痛、紧张型头痛与三叉神经血管系统，构成基础科学内容的主体。
• Cluster headache, trigeminal autonomic cephalalgias and other rare syndromes are covered through dedicated cohort and mechanistic studies.丛集性头痛、三叉神经自主神经性头痛及其他罕见综合征，通过专门的队列与机制研究得到覆盖。
• Clinical trials of acute and preventive treatments, including the CGRP monoclonal antibodies and gepants, appear frequently.急性与预防性治疗的临床试验，包括 CGRP 单克隆抗体与小分子 CGRP 受体拮抗剂，出现频率很高。
• Diagnostic classification, epidemiology, burden of disease and health services research are treated as core clinical science rather than background.诊断分类、流行病学、疾病负担与卫生服务研究被视为核心临床科学，而非背景材料。
• Imaging and neurophysiology, including functional MRI of migraine phases and quantitative sensory testing, form a growing methodological strand.影像与神经生理学，包括偏头痛各阶段的功能磁共振与定量感觉测试，构成不断增长的方法学脉络。
• Review articles, short communications, letters and guidelines complete the article mix, and the journal publishes the International Classification of Headache Disorders.综述、短篇通讯、读者来信与指南构成其余稿件类型，本刊并负责发布《国际头痛疾病分类》。

History

• The journal was established in 1981 as the official publication of the International Headache Society, at a point when headache medicine was seeking recognition as a neurological subspecialty.本刊于 1981 年创办，作为国际头痛学会的官方刊物，当时头痛医学正争取被承认为神经病学的一个亚专科。
• It was published for many years by Blackwell Publishing before the society moved the title to SAGE Publications, which now produces twelve issues a year.本刊长期由（Blackwell Publishing）出版，此后学会将刊物转交（SAGE Publications），现每年出版十二期。
• The first edition of the International Classification of Headache Disorders appeared in the journal in 1988, the second in 2004 and the third in 2018.《国际头痛疾病分类》第一版于 1988 年在本刊发表，第二版于 2004 年，第三版于 2018 年。
• The third edition runs to more than two hundred pages in a single issue and has informed the headache section of the World Health Organization's international classification of diseases.第三版以单期两百余页的篇幅刊出，并为世界卫生组织国际疾病分类中的头痛部分提供了依据。^[1]
• In 2024 the journal published the society's global practice recommendations for both acute and preventive pharmacological treatment of migraine.2024 年，本刊发表了该学会关于偏头痛急性期与预防性药物治疗的全球实践建议。
• The 2025 impact factor is 5.8, against 4.6 in 2024 and 6.075 in 2022, ranking 29th of 296 in clinical neurology.2025 年影响因子为 5.8，2024 年为 4.6，2022 年为 6.075，在临床神经病学类 296 种期刊中位列第 29。

Editors

• Simona Sacco, a neurologist at the University of L'Aquila in Italy, is editor-in-chief and has led several of the society's treatment recommendation projects.意大利拉奎拉大学的神经病学家 Simona Sacco 担任主编，并主持了该学会多项治疗建议项目。
• Marcelo Valença of the Federal University of Pernambuco in Brazil serves as deputy editor, giving the journal a Latin American editorial anchor.巴西伯南布哥联邦大学的 Marcelo Valença 担任副编辑，使期刊在拉丁美洲有了编辑支点。
• More than thirty associate editors cover headache medicine, neurology, psychology, genetics and imaging across Europe, the Americas, Asia and Australia.三十余位助理编辑覆盖头痛医学、神经病学、心理学、遗传学与影像，分布于欧洲、美洲、亚洲与澳大利亚。
• Seven junior editors share the editorial workload, and separate editors manage graphical abstracts and social media.七位青年编辑分担编辑工作量，另设编辑分管图文摘要与社交媒体。
• Peter Goadsby acts as publishing and scientific integrity advisor and David Dodick as ombudsman, roles that formalise the journal's handling of disputes.Peter Goadsby 担任出版与科学诚信顾问，David Dodick 担任申诉专员，这两个角色把争议处理程序制度化。
• The journal states an average of about five and a half weeks from submission to first decision, which is fast for a clinical neurology title.期刊公布自投稿至首次决定平均约五周半，对临床神经学期刊而言相当迅速。